Bayer/Onyx Stick To Advanced Cancer Setting With Stivarga’s GIST Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
New indication for third-line gastrointestinal stromal tumors, an area of high unmet need, builds on candidate’s initial approval in advanced colon cancer.